A new, pluronic-based, bone hemostatic agent that does not impair osteogenesis

Neurosurgery

Volumn 49, Issue 4, 2001, Pages 962-968

  Wang, Michael Y ^a,c   Armstrong, Jonathan K ^b   Fisher, Timothy C ^b   Meiselman, Herbert J ^b   McComb, Gordon J ^a   Levy, Michael L ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Department of Neurological Surgery ^*  (United States)

Author keywords

Bone hemostasis; Bone wax; Osteogenesis; Pluronic

Indexed keywords

BONE WAX; HEMOSTATIC AGENT; PLURONIC F88; PLURONIC P85; POLOXAMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BLEEDING; BONE DEVELOPMENT; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; FEMUR; FRACTURE NONUNION; HEMOSTASIS; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034812909     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200110000-00031     Document Type: Article

References (46)

1. Foreign body reactions and an associated histological artefact due to bone wax
2. Complications secondary to the use of bone wax in seven patients
3. The use of bone wax
4. Hemostasis and healing following median sternotomy
5. Haemorheological effects of a nonionic copolymer surfactant (poloxamer 188)
6. Bone morphogenetic protein excipients: Comparative observations on poloxamer
7. Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites
8. The use of allogeneic collagen and poloxamer as delivery systems for human demineralized bone matrix (hDBM)
9. Use of Pluronic F-68 to diminish fat emboli and hemolysis during cardiopulmonary bypass: A controlled clinical study
10. Blood substitutes: Fluids, drugs, or miracle solutions?
11. Experimental nonunion in dogs
12. New absorbable hemostatic bone wax: Experimental and clinical studies
13. Preparation of fat emulsions for intravenous alimentation
14. Antiseptic wax
15. Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated Fluosol DA 20%
16. Pharmacokinetics of RheothRx injection in healthy male volunteers
17. Effects of bone wax on bacterial clearance
18. A phase III multicenter, randomized, double-blind, placebo-controlled study of Flocor (purified poloxamer 188) in patients with sickle cell disease in acute vaso-occlusive crisis
19. Adjunctive use of a surface-active agent in extracorporeal circulation
20. The promotional effect of bone wax on experimental Staphylococcus aureus osteomyelitis
21. Polyethylene glycol/microfibrillar collagen composite as a new resorbable hemostatic bone wax
22. Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction: Results of a randomized, double-blind, placebo-controlled trial
23. Bone morphogenetic proteins: An update on basic biology and clinical relevance
24. Artificial skin: I - Preparation and properties of Pluronic F-127 gels for treatment of burns
25. A review of block polymer surfactants
26. Poloxamers in the pharmaceutical industry
27. Growth factors in bone
28. The effect of a composite of polyorthoester and demineralized bone on the healing of large segmental defects of the radius in rats
29. Effect of local hemostatics on bone induction in rats: A comparative study of bone wax, fibrin-collagen paste, and bioerodible polyorthoester with and without gentamycin
30. Regeneration of calvarial defects by a composite of bioerodible polyorthoester and demineralized bone in rats
31. Assessment in rats of a new bioerodible bone-wax-like polymer
32. Local hemostatic effects of microcrystalline partially deacetylated chitin hydrochloride
33. Clinical observations on the use of nonphosphatide (Pluronic) fat emulsions
34. Disposition in rats of a polyoxypropylene-polyoxyethylene copolymer used in plasma fractionation
35. Gelfoam paste in experimental laminectomy and cranial trephination: Hemostasis and bone healing
36. A study of labeled pluronic F-68 after intravenous injection into the dog
37. Biodegradable bone wax
38. The healing of segmental bone defects, induced by recombinant human bone morphogenic protein (rhBMP-2): A radiographic, histological, and biochemical study in rats